Exchange: NASDAQ·Updated 07:30 PM EDT

ALMR Alamar Biosciences Inc.

$30.80
$0.23
(0.75%)
Today
Closed $30.80
$0.00
(0.00%)
After Hours
Reported EarningsAug 10
Mkt Cap$2.14B
Vol142,949.00

About ALMR

Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.
50

Neutral Sentiment

How do you feel about ALMR?

Advertisement|Remove ads.